Viewing Study NCT06238167


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-03 @ 5:13 AM
Study NCT ID: NCT06238167
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-02
First Post: 2024-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module